ApprovalTrail

Medical device licence · 62084 · Class 2

FITC ANTI-LAMBDA PRIMARY ANTIBODY

Yes: licensed in Canada

Licence status Issued (active); first licensed March 18, 2003. It is in Health Canada’s list of active licences.
Licence number
62084
Licence holder
Ventana Medical Systems IncTucson, AZ, United States
Risk class
Class II (low to moderate risk)
Licence type
Single Device
First licensed
March 18, 2003
Devices covered
1

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • FITC ANTI-LAMBDA PRIMARY ANTIBODY

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.